Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03363204
Other study ID # 69HCL17_0281
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 8, 2018
Est. completion date December 28, 2018

Study information

Verified date August 2019
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is no accurate diagnosis method for bruxism for now. Consequences of bruxism over teeth, muscles and articulation of the jaw are important.

This study aims to develop a innovative tool in order to accurately rapidly diagnose bruxism in ambulatory evaluation.


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date December 28, 2018
Est. primary completion date December 28, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- adult from 18-70

- patients diagnosed with bruxism according to the following criteria:

- positive question at one of the following question:

- are you aware of your grinding?

- does your partner hear you grinding?

- are you aware that you are frequently tighten your jaws during the day and/or the night?

- are you tired and/or do experience jaws 'muscular pain in the morning.

- presence of at least one criteria:

- abnormal tooth wear or tooth prosthesis damages

- Hypertrophy of the masseter muscles

- patients agreeing to participate

- patient able to understand and follow the protocol

- patient with health insurance

Exclusion Criteria:

- patients with more than 2 missing tooth

- Severe troubles to correctly close the mouth.

- neurological disorder (Parkinson, Alzheimer) or psychiatric disorder

- Sleep disorder (insomnia, narcolepsy, sleep apnea, restless leg disorder)

- use of drugs that potentially impair sleep (benzodiazepines, neuroleptics, tricyclic antidepressants) alcohol or narcotics.

- complete or partial removal dental prosthesis or orthodontic device

- Patient under legal protection

- pregnant women

- Patients deprived of their freedom by a judicial or administrative decision

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BRUXENSE occlusal splint
Patients participating will put the BRUXENSE occlusal splint each night. During the night the device will collect data potentially related to bruxism. After each night the device will be cleaned with water and toothpaste and charged. This routine will be conducted over 10 consecutive nights.

Locations

Country Name City State
France Service de Consultations et de Traitements Dentaires, Hospices Civils de Lyon Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient rate with successful use of BRUXENSE occlusal splint The BRUXENSE occlusal splints correct use in real situation will be evaluated by measuring the percentage of subjects able to use this occlusal splints during 10 consecutive nights (6 hours minimum) without any pain or any discomfort. 10 nights is the necessary delay to record sufficient data to make a diagnosis. At day 10
Secondary Number of usable measurements The quality of collected data will be determined by the number of measurements that can be used to make a diagnosis of bruxism after 10 consecutive nights At day 10
Secondary Satisfaction scale score Subject satisfaction will be assessed thanks to a numeric scale going from 0 (not satisfied at all) to 10 (completely satisfied) At day 10
Secondary Proportion of patients diagnosed with bruxism Proportion of patients diagnosed with bruxism according to the BRUXENSE occlusal splints after the analysis of the data collected during 10 days. At day 10